Nuvectis Pharma Book Value Per Share Growth & History (NVCT)
Nuvectis Pharma's book value per share was $0.72 for fiscal 2025.
View full Nuvectis Pharma company overviewNuvectis Pharma annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0.72 | $0.22 | +43.94% |
| 2024 | 2024-12-31 | $0.50 | -$0.20 | −28.87% |
| 2023 | 2023-12-31 | $0.70 | -$0.24 | −25.17% |
| 2022 | 2022-12-31 | $0.94 | $3.38 | — |
| 2021 | 2021-12-31 | -$2.44 | — | — |
Nuvectis Pharma quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0.34 | -$0.37 | −51.85% |
| Q1 2026 | 2026-03-31 | $0.54 | -$0.35 | −39.53% |
| Q4 2025 | 2025-12-31 | $0.72 | $0.22 | +43.94% |
| Q3 2025 | 2025-09-30 | $0.94 | $0.36 | +61.75% |
| Q2 2025 | 2025-06-30 | $0.71 | $0.04 | +5.75% |
| Q1 2025 | 2025-03-31 | $0.89 | $0.12 | +16.06% |
| Q4 2024 | 2024-12-31 | $0.50 | -$0.20 | −28.87% |
| Q3 2024 | 2024-09-30 | $0.58 | -$0.39 | −39.94% |
| Q2 2024 | 2024-06-30 | $0.67 | -$0.51 | −43.40% |
| Q1 2024 | 2024-03-31 | $0.76 | -$0.00 | −0.38% |
| Q4 2023 | 2023-12-31 | $0.70 | -$0.24 | −25.17% |
| Q3 2023 | 2023-09-30 | $0.96 | -$0.43 | −30.72% |
| Q2 2023 | 2023-06-30 | $1.18 | $0.28 | +30.57% |
| Q1 2023 | 2023-03-31 | $0.77 | -$0.38 | −33.02% |
| Q4 2022 | 2022-12-31 | $0.94 | $3.38 | — |
| Q3 2022 | 2022-09-30 | $1.39 | — | — |
| Q2 2022 | 2022-06-30 | $0.90 | — | — |
| Q1 2022 | 2022-03-31 | $1.14 | — | — |
| Q4 2021 | 2021-12-31 | -$2.44 | — | — |
Nuvectis Pharma book value per share trends
Between the periods ended 2021-12-31 and 2025-12-31, Nuvectis Pharma's book value per share increased from -$2.44 to $0.72, a change of $3.16. The latest reported quarter, Q2 2026, shows $0.34.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nuvectis Pharma source filings ↗